BCM
FATE icon

Bayesian Capital Management’s Fate Therapeutics FATE Stock Holding History

Bayesian Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,174
Closed -$60.1K – 782
2024
Q3 		$60.1K Buy
+17,174
New +$66.8K 0.01% 620
2024
Q2 		– Sell
-39,800
Closed -$292K – 856
2024
Q1 		$292K Buy
39,800
+20,164
+103% +$125K 0.03% 557
2023
Q4 		$73.4K Sell
19,636
-18,600
-49% -$43.9K 0.01% 670
2023
Q3 		$81.1K Sell
38,236
-22,000
-37% -$72.9K 0.01% 622
2023
Q2 		$287K Buy
60,236
+31,900
+113% +$176K 0.03% 551
2023
Q1 		$162K Buy
28,336
+9,600
+51% +$57.9K 0.02% 636
2022
Q4 		$189K Buy
18,736
+3,900
+26% +$73.2K 0.03% 610
2022
Q3 		$332K Buy
+14,836
New +$429K 0.07% 385
2021
Q2 		– Sell
-6,300
Closed -$519K – 480
2021
Q1 		$519K Buy
+6,300
New +$604K 0.12% 223

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return